Predicting patients with COPD who are likely to exacerbate – is it feasible in primary care?

Freeman D, Price D, Jones R, Kerkhof M
NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 06.

By |September 13th, 2016|OPCRD|0 Comments

Investigating the proportion of community-based patients with COPD who meet eligibility criteria for published clinical trials of long-acting bronchodilator therapy for COPD: pilot phase

Halpin D, Bichel K, von Ziegenweidt J, Ali M, Price DB
NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 07.

By |September 13th, 2016|OPCRD|0 Comments

Blood eosinophils as a marker of COPD

Kerkhof M, Price D, Postma D, Papi A, Brusselle G, Agusti A, Anzueto A, Vogelmeier C, Ryan D, Freeman D, Thomas M, Pavord I, Bafadhel M, Roche N, Jones R, Popov T, Pizzichini E, Rigazio A
NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 10.

By |September 13th, 2016|OPCRD|0 Comments

Real life effectiveness of changing fixed-dose combination therapy from Seretides metered dose inhaler (MDI) to Flutiforms in UK patients with asthma

Lim D, Small I, Wolfe S, Hamill J, Gruffydd-Jones K, Daly C, Price D
NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 12.

By |September 13th, 2016|OPCRD|0 Comments

Relationships between database-recorded objective variables and GINA current control status

Martin R, Burden A, Dima A, Colice G, Pizzichini E, Popov T, Papadopoulos N, Reddel H, Kaplan A, Holbrook J, Brusselle G, Price D

NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 13.

By |September 13th, 2016|OPCRD|0 Comments

Episode pattern and healthcare utilisation in patients with seasonal allergic rhinitis

Pitman R, Paracha N, Parker C, Acaster S, Bachert C, Bousquet J, Price D

NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 14.

By |September 13th, 2016|OPCRD|0 Comments

Dynamics of treatment within a year in patients diagnosed with either allergic, non-allergic rhinitis or hay fever over the period 1992–2012

Price D, Scadding GK, Bachert C, Saleh H, Nasser S, Bichel K, Carter V, Von Ziegenweidt J, Ryan D

NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 19.

By |September 13th, 2016|OPCRD|0 Comments

Identifying factors, including biomarkers, associated with future asthma exacerbation and hospitalisation risk from routine UK primary care clinical records

Price DB, Bleecker ER, Campbell JD, Corrigan CJ, Pavord ID, Wenzel SE, Thomas M, Clark A, Chisholm A, Rigazio A, Burden A, Ashton VL, Wilson AM; on behalf of the Respiratory Effectiveness Group

NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 21.

By |September 13th, 2016|OPCRD|0 Comments

Intranasal corticosteroid treatment failure in allergic rhinitis: assessment of unmet need by measuring shift to multiple therapies

Price D, Scadding GK, Bachert C, Saleh H, Nasser S, Carter V, Von Ziegenweidt J, Ryan D

NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 22.

By |September 13th, 2016|OPCRD|0 Comments

Real-life prescribing and outcomes of long-acting muscarinic antagonist (LAMA) therapy for adult patients with asthma in UK clinical practice

Price D, Kaplan A, Jones R, Freeman D, Burden A, Gould S, von Ziegenweidt J, Ali M, Thomas M

NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 23.

By |September 13th, 2016|OPCRD|0 Comments